4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-25-002103
Principal Accounting Officer acquired 11,850 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dunn Edmund Principal Accounting Officer | 2025-01-02 | Grant or award | +11,850 | 25,794 | D | ||
| Derivatives | |||||||
| Dunn Edmund Principal Accounting Officer | 2025-01-02 | Grant or award · Stock Option (Right to Buy) | +53,400 | 53,400 | D | ||
Loading xslF345X05/ownership.xml…